Cosmo Pharmaceuticals’ Shareholders approve all Agenda Items at Extraordinary General Meeting
Cosmo Pharmaceuticals N.V. C43) (“Cosmo”) announced that its shareholders approved all agenda items at today’s virtual extraordinary general meeting of shareholders.